Dr. Shyam Bihari Bansal

About Dr. Shyam Bihari Bansal

Dr. Shyam Bihari Bansal is Vice Chairman of the Institute of Nephrology and Kidney Transplant at Medanta – The Medicity in Gurugram, one of India's leading multi-specialty healthcare institutions. With over 20 years of clinical experience, he is a highly accomplished nephrologist recognized internationally for his pioneering work in kidney transplantation and critical care nephrology. He holds the prestigious fellowships of FRCP (Royal College of Physicians, London), FASN (American Society of Nephrology, 2020), and FISN (Indian Society of Nephrology, 2016), cementing his standing as a thought leader in the field.

Dr. Bansal has managed more than 3,000 kidney transplant recipients and is known for his expertise in complex transplant scenarios, particularly ABO-incompatible kidney transplantation—a field in which he authored India's first clinical series. His clinical depth spans hemodialysis, peritoneal dialysis, continuous renal replacement therapy, acute kidney injury management, chronic kidney disease, and immunosuppression management. He has published over 140 original articles and book chapters with more than 17,600 citations, reflecting significant contributions to nephrology literature. His landmark research includes the first report of kidney transplantation in an HIV-positive patient in India and the first steroid-free kidney transplant protocol in the country.

Dr. Bansal has built a strong reputation among international patients from the Gulf region, Africa, and South Asia who seek advanced transplant services. He conducts regular consultations for overseas patients through telemedicine, and Medanta's dedicated international patient services facilitate seamless coordination of pre-transplant evaluation, surgery, and post-operative care for patients traveling to Gurugram.

Medanta – The Medicity is a JCI-accredited 1,200-bed tertiary care facility renowned for its nephrology and transplant programs. The hospital offers state-of-the-art ICU facilities, an in-house blood bank, and a multidisciplinary transplant team, making it a premier destination for kidney transplant recipients and patients with complex renal disease. The institute's combination of advanced technology, experienced surgical teams, and comprehensive post-transplant follow-up programs ensures international patients receive world-standard care in India.

When considering treatment in India, international patients benefit from significantly lower treatment costs compared to Western centres, access to experienced transplant programs, and the personal attention afforded by institutions like Medanta. Dr. Bansal's English fluency and his hospital's established protocols for international patients simplify the entire journey from consultation to recovery and long-term follow-up.